Vesalius Biocapital has closed its VBC-III fund with €120m of equity commitments, the largest fund raised so far by the Luxemburg-based capital investor.
So far the pool, the third of Vesalius Biocapital’s funds, has invested in later-stage European life sciences companies that are...






